[ALNY] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -193.31%
YoY- 33.55%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 659,825 494,333 439,718 750,530 318,754 319,290 335,035 57.18%
PBT -11,167 -63,587 -137,687 150,741 -274,209 -172,362 -207,021 -85.74%
Tax 5,722 2,348 183 2,988 1,815 1,739 472 428.52%
NP -16,889 -65,935 -137,870 147,753 -276,024 -174,101 -207,493 -81.24%
Tax Rate - - - -1.98% - - - -
Total Cost 676,714 560,268 577,588 602,777 594,778 493,391 542,528 15.89%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -2.56 -13.34 -31.35 19.69 -86.59 -54.53 -61.93 -88.06%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.13 -0.52 -1.10 1.18 -2.21 -1.40 -1.68 -81.86%
EPS Diluted -0.13 -0.52 -1.10 1.15 -2.21 -1.40 -1.68 -81.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.